{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:35:37Z","timestamp":1790386537312,"version":"4.1.0"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS058784"],"award-info":[{"award-number":["R01 NS058784"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>Stroke is the leading cause of serious long-term disability, significantly reducing mobility in almost half of the affected patients aged 65 years and older. There are currently no proven neurorestorative treatments for chronic stroke. To address the complex problem of restoring function in ischemic brain tissue, stem cell transplantation-based therapies have emerged as potential restorative therapies. Aligning with the major cell types found within the ischemic brain, stem-cell-based clinical trials for ischemic stroke have fallen under three broad cell lineages: hematopoietic, mesenchymal, and neural. In this review article, we will discuss the scientific rationale for transplanting cells from each of these lineages and provide an overview of published and ongoing trials using this framework.<\/jats:p>","DOI":"10.3389\/fnagi.2020.575990","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T05:20:10Z","timestamp":1607923210000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Revisiting Stem Cell-Based Clinical Trials for Ischemic Stroke"],"prefix":"10.3389","volume":"12","author":[{"given":"Joy Q.","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary K.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1002\/jnr.22146","article-title":"Extracellular matrix produced by bone marrow stromal cells and by their derivative, SB623 cells, supports neural cell growth","volume":"87","author":"Aizman","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1056\/NEJMoa1713973","article-title":"Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging","volume":"378","author":"Albers","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e01214","DOI":"10.1002\/brb3.1214","article-title":"Neural stem cell therapy for stroke: a multimechanistic approach to restoring neurological function","volume":"9","author":"Baker","year":"2019","journal-title":"Brain Behav."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.5966\/sctm.2013-0178","article-title":"Intra-arterial immunoselected CD34+ stem cells for acute ischemic stroke","volume":"3","author":"Banerjee","year":"2014","journal-title":"Stem Cells Transl. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fneur.2019.00211","article-title":"Mesenchymal stem cell-derived extracellular vesicle therapy for stroke: challenges and progress","volume":"10","author":"Bang","year":"2019","journal-title":"Front. Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/ana.20501","article-title":"Autologous mesenchymal stem cell transplantation in stroke patients","volume":"57","author":"Bang","year":"2005","journal-title":"Ann. Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1097\/00001756-199912160-00022","article-title":"Human NT2\/D1 cells differentiate into functional astrocytes","volume":"10","author":"Bani-Yaghoub","year":"1999","journal-title":"Neuroreport"},{"key":"B8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.expneurol.2009.10.010","article-title":"Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection","volume":"221","author":"Barbosa da Fonseca","year":"2010","journal-title":"Exp. Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/sctm.16-0397","article-title":"Human neural stem cell biodistribution and predicted tumor coverage by a diffusible therapeutic in a mouse glioma model","volume":"6","author":"Barish","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: a report from the american heart association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411587","article-title":"A randomized trial of intraarterial treatment for acute ischemic stroke","volume":"372","author":"Berkhemer","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000333381","article-title":"Autologous mesenchymal stem cells in chronic stroke","volume":"1","author":"Bhasin","year":"2011","journal-title":"Cerebrovasc. Dis. Extra"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.clineuro.2012.10.015","article-title":"Stem cell therapy: a clinical trial of stroke","volume":"115","author":"Bhasin","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"key":"B14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000446404","article-title":"Paracrine mechanisms of intravenous bone marrow-derived mononuclear stem cells in chronic ischemic stroke","volume":"6","author":"Bhasin","year":"2016","journal-title":"Cerebrovasc. Dis. Extra"},{"key":"B15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.nbd.2009.10.003","article-title":"Optimizing the success of cell transplantation therapy for stroke","volume":"37","author":"Bliss","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B16","first-page":"17","article-title":"Global characterization and genomic stability of human multistem, a multipotent adult progenitor cell","volume":"4","author":"Boozer","year":"2009","journal-title":"J. Stem Cells"},{"key":"B17","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1006\/exnr.1997.6730","article-title":"Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats","volume":"149","author":"Borlongan","year":"1998","journal-title":"Exp. Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa1414792","article-title":"Endovascular therapy for ischemic stroke with perfusion-imaging selection","volume":"372","author":"Campbell","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1742-2094-7-74","article-title":"The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia","volume":"7","author":"Ceulemans","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1161\/01.str.32.4.1005","article-title":"Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats","volume":"32","author":"Chen","year":"2001","journal-title":"Stroke"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3727\/096368914X678562","article-title":"Intracerebral implantation of autologous peripheral blood stem cells in stroke patients: a randomized phase II study","volume":"23","author":"Chen","year":"2014","journal-title":"Cell Transplant."},{"key":"B22","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.3727\/096368913X672154","article-title":"Multiple cell transplantation based on an intraparenchymal approach for patients with chronic phase stroke","volume":"22","author":"Chen","year":"2013","journal-title":"Cell Transplant."},{"key":"B23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1474-4422(10)70314-8","article-title":"Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial","volume":"10","author":"Chollet","year":"2011","journal-title":"Lancet Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"ENEURO.0076-18.2018","DOI":"10.1523\/ENEURO.0076-18.2018","article-title":"Liquefaction of the brain following stroke shares a similar molecular and morphological profile with atherosclerosis and mediates secondary neurodegeneration in an osteopontin-dependent mechanism","volume":"5","author":"Chung","year":"2018","journal-title":"eNeuro"},{"key":"B26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1742-2094-8-133","article-title":"Comparing the immunosuppressive potency of naive marrow stromal cells and Notch-transfected marrow stromal cells","volume":"8","author":"Dao","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1479-5876-11-81","article-title":"Comparing the angiogenic potency of naive marrow stromal cells and Notch-transfected marrow stromal cells","volume":"11","author":"Dao","year":"2013","journal-title":"J. Transl. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S1474-4422(09)70054-7","article-title":"Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use","volume":"8","author":"Dirnagl","year":"2009","journal-title":"Lancet Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/j.1476-5381.2009.00211.x","article-title":"Stroke research at a road block: the streets from adversity should be paved with meta-analysis and good laboratory practice","volume":"157","author":"Dirnagl","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00415-006-0362-1","article-title":"Neurological and functional recovery in human stroke are associated with peripheral blood CD34+ cell mobilization","volume":"254","author":"Dunac","year":"2007","journal-title":"J. Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/jcbfm.2013.91","article-title":"Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke","volume":"33","author":"Eckert","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/sctm.18-0012","article-title":"Autologous endothelial progenitor cells transplantation for acute ischemic stroke: a 4-year follow-up study","volume":"8","author":"Fang","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.3727\/096368912X612512","article-title":"Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke","volume":"21","author":"Friedrich","year":"2012","journal-title":"Cell Transplant."},{"key":"B33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.brainres.2009.01.062","article-title":"Treatment with bone marrow mononuclear cells induces functional recovery and decreases neurodegeneration after sensorimotor cortical ischemia in rats","volume":"1266","author":"Giraldi-Guimardes","year":"2009","journal-title":"Brain Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1414905","article-title":"Randomized assessment of rapid endovascular treatment of ischemic stroke","volume":"372","author":"Goyal","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.stemcr.2019.07.002","article-title":"Long-term safety, immunologic response and imaging outcomes following neural stem cell transplantation for Pelizaeus-Merzbacher disease","volume":"13","author":"Gupta","year":"2019","journal-title":"Stem Cell Reports"},{"key":"B36","doi-asserted-by":"publisher","first-page":"155ra137","DOI":"10.1126\/scitranslmed.3004373","article-title":"Neural stem cell engraftment and myelination in the human brain","volume":"4","author":"Gupta","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s10072-014-2016-x","article-title":"Novel roles of perivascular nerves on neovascularization","volume":"36","author":"Hao","year":"2015","journal-title":"Neurol. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/17460441.2019.1573984","article-title":"Animal models of ischemic stroke and their impact on drug discovery","volume":"14","author":"Hermann","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"B40","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S1474-4422(17)30046-7","article-title":"Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"16","author":"Hess","year":"2017","journal-title":"Lancet Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3727\/096368912X657936","article-title":"In vivo and in vitro characterization of the angiogenic effect of CTX0E03 human neural stem cells","volume":"22","author":"Hicks","year":"2013","journal-title":"Cell Transplant."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/brain\/awr063","article-title":"Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke","volume":"134","author":"Honmou","year":"2011","journal-title":"Brain"},{"key":"B43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature00870","article-title":"Pluripotency of mesenchymal stem cells derived from adult marrow","volume":"418","author":"Jiang","year":"2002","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1056\/NEJMoa1503780","article-title":"Thrombectomy within 8 hours after symptom onset in ischemic stroke","volume":"372","author":"Jovin","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0140-6736(16)30513-X","article-title":"Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study","volume":"388","author":"Kalladka","year":"2016","journal-title":"Lancet"},{"key":"B46","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1182\/blood.V75.10.1947.1947","article-title":"Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells","volume":"75","author":"Kastan","year":"1990","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1751-7133.2009.00101.x","article-title":"Bone marrow-derived aldehyde dehydrogenase-bright stem and progenitor cells for ischemic repair","volume":"15","author":"Keller","year":"2009","journal-title":"Congest. Heart Fail."},{"key":"B48","doi-asserted-by":"publisher","first-page":"11839","DOI":"10.1073\/pnas.0404474101","article-title":"Transplanted human fetal neural stem cells survive, migrate and differentiate in ischemic rat cerebral cortex","volume":"101","author":"Kelly","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B49","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11373-004-8183-7","article-title":"T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance and suppression","volume":"12","author":"Klyushnenkova","year":"2005","journal-title":"J. Biomed. Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3171\/jns.2005.103.1.0038","article-title":"Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial","volume":"103","author":"Kondziolka","year":"2005","journal-title":"J. Neurosurg."},{"key":"B51","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1212\/wnl.55.4.565","article-title":"Transplantation of cultured human neuronal cells for patients with stroke","volume":"55","author":"Kondziolka","year":"2000","journal-title":"Neurology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1479-5876-7-97","article-title":"Inflammatory mechanisms in ischemic stroke: therapeutic approaches","volume":"7","author":"Lakhan","year":"2009","journal-title":"J. Transl. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/sctm.18-0008","article-title":"Allogeneic umbilical cord blood infusion for adults with ischemic stroke: clinical outcomes from a phase I safety study","volume":"7","author":"Laskowitz","year":"2018","journal-title":"Stem Cells Transl. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/s0301-472x(03)00110-3","article-title":"HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells","volume":"31","author":"Le Blanc","year":"2003","journal-title":"Exp. Hematol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cells"},{"key":"B56","doi-asserted-by":"publisher","first-page":"33038","DOI":"10.1038\/srep33038","article-title":"Microvesicles from brain-extract-treated mesenchymal stem cells improve neurological functions in a rat model of ischemic stroke","volume":"6","author":"Lee","year":"2016","journal-title":"Sci. Rep."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1161\/STROKEAHA.119.026318","article-title":"Phase I\/II study of safety and preliminary efficacy of intravenous allogeneic mesenchymal stem cells in chronic stroke","volume":"50","author":"Levy","year":"2019","journal-title":"Stroke"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1097\/00004647-200009000-00006","article-title":"Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice","volume":"20","author":"Li","year":"2000","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.2147\/NDT.S104917","article-title":"Intravenous administration of adipose tissue-derived stem cells enhances nerve healing and promotes BDNF expression via the TrkB signaling in a rat stroke model","volume":"12","author":"Li","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"B60","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1161\/STROKEAHA.108.525386","article-title":"Good laboratory practice: preventing introduction of bias at the bench","volume":"40","author":"Macleod","year":"2009","journal-title":"Stroke"},{"key":"B61","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s13063-015-0864-1","article-title":"The focus, affinity and effects trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trials","volume":"16","author":"Mead","year":"2015","journal-title":"Trials"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1161\/01.str.0000027693.50675.c5","article-title":"Effects of implantation site of stem cell grafts on behavioral recovery from stroke damage","volume":"33","author":"Modo","year":"2002","journal-title":"Stroke"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1161\/STROKEAHA.112.659409","article-title":"Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial","volume":"43","author":"Moniche","year":"2012","journal-title":"Stroke"},{"key":"B64","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/jnnp-2019-322515","article-title":"Intracerebral implantation of human neural stem cells and motor recovery after stroke: multicentre prospective single-arm study (PISCES-2)","volume":"91","author":"Muir","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B65","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1706442","article-title":"Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct","volume":"378","author":"Nogueira","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/ccd.23066","article-title":"A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia","volume":"78","author":"Perin","year":"2011","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"B67","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ahj.2011.11.020","article-title":"Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure","volume":"163","author":"Perin","year":"2012","journal-title":"Am. Heart. J."},{"key":"B68","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.expneurol.2005.12.011","article-title":"A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke","volume":"199","author":"Pollock","year":"2006","journal-title":"Exp. Neurol."},{"key":"B69","first-page":"221","article-title":"Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study","volume":"136","author":"Prasad","year":"2012","journal-title":"Indian J. Med. Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1161\/STROKEAHA.114.007028","article-title":"Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial","volume":"45","author":"Prasad","year":"2014","journal-title":"Stroke"},{"key":"B71","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.3727\/096368914X684961","article-title":"A two-year follow-up study of cotransplantation with neural stem\/progenitor cells and mesenchymal stromal cells in ischemic stroke patients","volume":"23","author":"Qiao","year":"2014","journal-title":"Cell Transplant."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1182\/blood.v98.9.2615","article-title":"Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells","volume":"98","author":"Reyes","year":"2001","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2217\/rme.13.2","article-title":"Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients","volume":"8","author":"Rosado-de-Castro","year":"2013","journal-title":"Regen. Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.exger.2017.01.008","article-title":"Stem cell therapies in preclinical models of stroke. Is the aged brain microenvironment refractory to cell therapy?","volume":"94","author":"Sandu","year":"2017","journal-title":"Exp. Gerontol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1056\/NEJMoa1415061","article-title":"Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke","volume":"372","author":"Saver","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/jama.2016.13647","article-title":"Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis","volume":"316","author":"Saver","year":"2016","journal-title":"JAMA"},{"key":"B77","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000086518","article-title":"Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study","volume":"20","author":"Savitz","year":"2005","journal-title":"Cerebrovasc. Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ana.22458","article-title":"Intravenous autologous bone marrow mononuclear cells for ischemic stroke","volume":"70","author":"Savitz","year":"2011","journal-title":"Ann. Neurol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1161\/CIRCULATIONAHA.117.030659","article-title":"A phase 2 randomized, sham-controlled trial of internal carotid artery infusion of autologous bone marrow-derived ALD-401 cells in patients with recent stable ischemic stroke (RECOVER-Stroke)","volume":"139","author":"Savitz","year":"2019","journal-title":"Circulation"},{"key":"B80","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ana.25643","article-title":"Why most acute stroke studies are positive in animals but not in patients: a systematic comparison of preclinical, early phase and phase 3 clinical trials of neuroprotective agents","volume":"87","author":"Schmidt-Pogoda","year":"2020","journal-title":"Ann. Neurol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"234095","DOI":"10.1155\/2014\/234095","article-title":"Autologous bone marrow mononuclear cells intrathecal transplantation in chronic stroke","volume":"2014","author":"Sharma","year":"2014","journal-title":"Stroke Res. Treat."},{"key":"B82","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/1545968314525856","article-title":"Bone marrow stromal cells rescue ischemic brain by trophic effects and phenotypic change toward neural cells","volume":"29","author":"Shichinohe","year":"2015","journal-title":"Neurorehabil. Neural Repair"},{"key":"B83","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1523\/JNEUROSCI.5165-05.2006","article-title":"Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats","volume":"26","author":"Shyu","year":"2006","journal-title":"J. Neurosci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"924","DOI":"10.2340\/16501977-2033","article-title":"Dalfampridine in chronic sensorimotor deficits after ischemic stroke: a proof of concept study","volume":"47","author":"Simpson","year":"2015","journal-title":"J. Rehabil. Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/stem.1024","article-title":"Implantation site and lesion topology determine efficacy of a human neural stem cell line in a rat model of chronic stroke","volume":"30","author":"Smith","year":"2012","journal-title":"Stem Cells"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1161\/STROKEAHA.116.012995","article-title":"Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1\/2a study","volume":"47","author":"Steinberg","year":"2016","journal-title":"Stroke"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2018.5.JNS173147","article-title":"Two-year safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow-derived mesenchymal stem cells (SB623): a phase 1\/2a study","volume":"131","author":"Steinberg","year":"2018","journal-title":"J. Neurosurg."},{"key":"B88","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pneurobio.2017.07.004","article-title":"Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms","volume":"158","author":"Stonesifer","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1177\/1545968309335978","article-title":"The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion","volume":"23","author":"Stroemer","year":"2009","journal-title":"Neurorehabil. Neural Repair"},{"key":"B90","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3233\/RNN-2009-0483","article-title":"Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study","volume":"27","author":"Suarez-Monteagudo","year":"2009","journal-title":"Restor. Neurol. Neurosci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"6029","DOI":"10.3390\/ijms20236029","article-title":"Recent advances in mono- and combined stem cell therapies of stroke in animal models and humans","volume":"20","author":"Surugiu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1089\/scd.2015.0160","article-title":"Intravenous autologous bone marrow mononuclear cell transplantation for stroke: phase1\/2a clinical trial in a homogeneous group of stroke patients","volume":"24","author":"Taguchi","year":"2015","journal-title":"Stem Cells Dev."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e74857","DOI":"10.1371\/journal.pone.0074857","article-title":"Stem cell recruitment of newly formed host cells via a successful seduction? Filling the gap between neurogenic niche and injured brain site","volume":"8","author":"Tajiri","year":"2013","journal-title":"PLoS One"},{"key":"B94","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/jnr.10412","article-title":"Engraftment of sorted\/expanded human central nervous system stem cells from fetal brain","volume":"69","author":"Tamaki","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3727\/096368910X494885","article-title":"Human mesenchymal stromal cells and their derivative, SB623 cells, rescue neural cells via trophic support following in vitro ischemia","volume":"19","author":"Tate","year":"2010","journal-title":"Cell Transplant."},{"key":"B96","doi-asserted-by":"publisher","first-page":"14720","DOI":"10.1073\/pnas.97.26.14720","article-title":"Direct isolation of human central nervous system stem cells","volume":"97","author":"Uchida","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B97","doi-asserted-by":"publisher","first-page":"155ra136","DOI":"10.1126\/scitranslmed.3004371","article-title":"Human neural stem cells induce functional myelination in mice with severe dysmyelination","volume":"4","author":"Uchida","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1161\/01.str.32.4.1012","article-title":"Resolution of stroke deficits following contralateral grafts of conditionally immortal neuroepithelial stem cells","volume":"32","author":"Veizovic","year":"2001","journal-title":"Stroke"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1177\/0963689718802754","article-title":"Neuroprotective action of human wharton\u2019s jelly-derived mesenchymal stromal cell transplants in a rodent model of stroke","volume":"27","author":"Wu","year":"2018","journal-title":"Cell Transplant."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1089\/scd.2009.0011","article-title":"Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals","volume":"18","author":"Yasuhara","year":"2009","journal-title":"Stem Cells Dev."},{"key":"B101","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s40261-017-0558-4","article-title":"Effects of central nervous system drugs on recovery after stroke: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Yeo","year":"2017","journal-title":"Clin. Drug Investig."},{"key":"B102","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.nbd.2018.01.007","article-title":"Glial scars are permeable to the neurotoxic environment of chronic stroke infarcts","volume":"112","author":"Zbesko","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"B104","doi-asserted-by":"publisher","first-page":"e113972","DOI":"10.1371\/journal.pone.0113972","article-title":"Stroke increases neural stem cells and angiogenesis in the neurogenic niche of the adult mouse","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.4103\/1673-5374.211189","article-title":"Neural differentiation of human Wharton\u2019s jelly-derived mesenchymal stem cells improves the recovery of neurological function after transplantation in ischemic stroke rats","volume":"12","author":"Zhang","year":"2017","journal-title":"Neural Regen. Res."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-020-00814-z","article-title":"Extracellular vesicles derived from neural progenitor cells\u2013a preclinical evaluation for stroke treatment in mice","author":"Zheng","year":"2020","journal-title":"Transl. Stroke Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1517\/14712598.2012.691161","article-title":"Human cord blood applications in cell therapy: looking back and look ahead","volume":"12","author":"Zhou","year":"2012","journal-title":"Expert Opin. Biol. Ther."}],"updated-by":[{"DOI":"10.3389\/fnagi.2022.875925","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000}}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2020.575990\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T17:05:58Z","timestamp":1646931958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2020.575990\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":106,"alternative-id":["10.3389\/fnagi.2020.575990"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2020.575990","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fnagi.2022.875925","asserted-by":"object"}]},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,14]]},"article-number":"575990"}}